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Summary.-Incompleteness of ascertainment of new cases of any disease leads to
underestimation of its incidence rate and may result in false assumptions about
incidence trends if incompleteness varies over the course of time (Fraser et al., 1978).
We report an attempt to assess the completeness of ascertainment in a cancer registry
in the North-Western Region of England using a method based on independent
comparison with accurate morbidity data. A total of 1955 verified cases of cancer
from 5 independent sources covering 11 sites were used in the study. The corrected
mean level of overall registration completeness was found to be94o% but this varied
appreciably with site and source of data. Independent comparison is recommended
as an effective method for estimating the completeness of cancer registration.
ESTIMATES OF CANCER INCIDENCE must
be based on complete, reliable and timely
data if an up-to-date and accurate picture
of the problem posed by cancer in a
specified population is to be presented. It
is therefore desirable that every cancer
registry should be able to quantify the
level of completeness at which it operates.
Various methods have been proposed for
estimating the completeness of cancer regi-
stration in a population-based cancer regi-
stration system (Waterhouse et al., 1976).
Mostofthe methods thathave been applied
to the problem in England and Wales
(Macdonald-Davies & Donnan, 1978; Hill
etal., 1972; Lecketal., 1976; Faulkner etal.,
1969) rely on comparison with mortality
datawhichlimittheirvalidity (Hansluwka,
1978). Morbidity data, if available, are
usually more reliable but they are difficult
and costly to obtain because they require
skilled manpower, time and expensive
resources and entail the cooperation of all
those concerned with the treatment and
care of cancer patients. Although it has
been observed that itisimpossible to check
on the completeness ofregistration without
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some form of independent ascertainment
(OfficeofPopulation Censuses andSurveys,
1970), no attempts to apply such a method
seem to have been made in England and
Wales. Our method of independent com-
parison is new in that it is based on mor-
bidity data derived from verified cases of
cancer.
METHOD
We first undertook a general review of the
registry data for the study period and made a
general assessment of the functions and
operations of the cancer registry. These
included the number of extra-regional cases,
the proportion of cases alive and dead each
year, and the category of registration-that
is, whether a case attended hospital and was
notified, attended hospital but was not noti-
fied, or never attended hospital at all.
Although the registry was started in 1962,
there is evidence that registration in the early
vears of its operations was seriously incom-
plete (Geary et al., 1979) and the N.H.S.
reorganization of 1974 changed appreciably
the registry's catchment area and population.
We chose to study the period 1974-77 so that
a constant homogeneous resident population
would be investigated. In addition to theU. NWENE AND A. SMITH
identification of extra-regional cases and the
categorization of cases registered, an attempt
was made to account for the few long-term
survivors who never attended hospital and
were not notified. These cases are usually lost
to registration. In order to estimate and
correct for these cases it was also necessary
during the review of the data to ascertain
the total number of cases registered during
each year of the study, the proportion of
these received within the same year, the
proportion ascertained only at death and the
proportion that never attended hospital.
For the main part of our study we were
given access to a number of independently
maintained lists of cancer patients within the
region which were known to be reliable and
complete. Some of these related to particular
hospitals where recording and follow-up is
meticulously maintained and some are region-
wide lists of patients with particular tumours
which have been made the subject of special
clinical and histological study. The lists
provide test data in which diagnosis is likely
to be very reliable and ascertainment very
complete and they provide a stringent test
of the registry's completeness. From these
lists we abstracted personal and clinical data
including the name of the referring physician
or hospital, the date of first diagnosis or
treatment, date of admission, histopathologi-
cal confirmation, fate at the date of last
follow-up, date of death or loss to follow-up,
any postmortem findings, duration of follow-
up or survival, and the result of any subse-
quent review of histology. Records were
obtainedinthis wayfor 1955 patients covering
11 sites from 3 hospitals in the region, from 1
regional cancer study and from an institution
participating actively in cancer control pro-
grammes. The chosen sites were of moderate
to low fatality (Cancer Research Campaign,
1979). This was useful because in high-
fatality sites registration rates tend to
approximate to mortality rates (World Health
Organization, 1979), and comparison with
morbidity data offers less advantage. We
compared the abstracted data against the
registry master file which is compiled from
notifications from all hospitals in the region
and all death notifications received from the
Office of Population Censuses and Surveys
(OPCS). The proportion of listed registrable
cases found to be actually recorded at the
registry estimates the registration complete-
ness.
RESULT
The total number of cancer cases noti-
fied and registered in the region show a
gradual but steady increase over the period
studied (TableI). About 85% ofeachyear's
registrations are registered in the same
calendar year as diagnosis, the remaining
15% often take up to 3 years to be regis-
tered. About 66% of registered patients
die during the calendar year of their
registration. Each year about 400 of
registrations never attend hospital and for
all of these registration is accomplished
posthumously. Virtually all cancer deaths
are registered within the calendar year in
which they occur. The number of cases
registered from death certificates only
(dco) showed a steady decline in the
period studied, being 10.8% in 1974 and
7 70 in 1977, while the total yearly
registrations increased. Thus there was a
comparative decline in dco registration
rates of 4000 over the study period.
Among the 1955 cases used for the
study 184 (9.5%0) were extraregional and
non-registrable. Of the remaining 1771
registrable cases 1703 were registered at
the registry, giving a mean percentage
completeness of registration of 96.2% in
relation to the sources of data used for
the study (Table II). We excluded 22
cases which, although they were actually
registered, could not be unequivocally
classified as site-specific because of the
appreciable and irreconcilable differences
in the recorded diagnoses between the
lists and the registry records. Such errors
in the recording of primary sites for
cancer have been documented by other
workers (Leck et al., 1976; Abramson etal.,
1971; Waldron & Vickerstaff, 1977) and
are inevitable in any thorough matching
of appreciably large numbers of records
from 2 independent sources. Most of these
cases had been subjected to histological
reviews which had resulted in changed
diagnoses that may not have been notified
to the registry. After the above data
reconciliation 1354 registrable site-specific
cases covering 11 sites were left: 1293 of
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TABLE I.-Trend in cancer registrations 1974-77-North-Western Region
Total
registrations
15951
15910
16611
16372
Percentage of total registrations
Hospital Dead Registrations
notifications within Never from death
within same same attended certificates
year year hospital only
85-2 66-5 4-4 10-8
(33.6)*
85-9 66*8 4 0 8-7
(33-2)
85.8 66-1 3-8 8-1
(33.9)
85-6 66*2 3-8 7-7
(33 8)
*Proportion of surviving cases in each year in brackets.
TABLE II.-Percentage completeness of cancer registration by sources of data
Source
Hospital A
Hospital B
Hospital C
Manchester Children's Tumour
Registry
Ovarian Tumour Study
Total
Number
of cases
obtained
296
979
82
395
203
1955
Extra-
regional
cases
11
173
0
0
0
184
Registrable
cases
285
806
82
395
203
1771
Registered
cases
272
772
70
389
200
1703
Percentage
completeness
95.4
95 8
85-4
98-4
98-5
96-2
TABLE III.-Percentage completeness of cancer registration by sites
Site
1 Bladder
2 Breast
3 Cervix
4 Colon
5 Hodgkin's disease
6 Malignant melanoma of skin
7 Multiple myeloma
8 Non-Hodgkin's lymphoma
9 Ovary
10 Salivary glands
11 Testis (excluding lymphomas)
Total
Number
of cases
85
116
60
95
238
142
85
310
203
56
148
1538
these cases were registered, giving a mean
site-specific level ofcompleteness of95.5%,
ranging from 81-6% for carcinoma of the
cervix to 98.5% for cancer of the ovary.
The site data are presented in Table III,
which excludes cases from the Children's
Tumour Registry which has a completely
different site distribution. A factor which
may affect the apparent level of complete-
ness is the number of diagnosed cancer
survivors who never attended hospital.
Extra-
regional
cases
2
4
0
5
47
25
15
44
0
3
39
Registrable
cases
83
112
60
90
191
117
70
266
203
53
109
184 1354
Registered
cases
80
104
49
88
184
115
68
256
200
48
101
1293
Percentage
completeness
96-4
92-8
81-6
97.7
96-3
98-3
97-1
96-2
98-5
90-6
92-7
95.5
Patients who remain alive but do not
attend hospital cannot be registered, since
death registration and notification by
hospitals are the only sources ofregistered
cases. Equally, such patients will be un-
likely to appear in the independent lists
with which we are comparing our regis-
tered cases. Obviously, we have no means
of directly estimating the number of such
cases. However, if we assume that the
proportion of survivors not attending
Year
1974
1975
1976
1977
1
2
3
4
5
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TABLE IV. Corrected completeness of registration by sources of data
Source
Registrable
cases
(N)
Hospital A
Hospital B
Hospital C
Mianclhester Chlildren's
Tumour Registry
Ovarian Tuimour Study
Total
285
806
82
395
203
1771
Estimate(d
unregistere(l
survivors*
(s = 0 *0136N)
4
11
1
5
3
24
Total cases
registrable
(N+s)
289
887
83
400
206
1795
Cases
registere(l
(R)
272
772
7()
389
200
1703
*RouLndedl to nearest wlhole number.
hospitals is similar to the proportion of
dead cases that did not attend hospital
an estimate can be derived. Thus 340/o x
4%0=136% of all registrable cases fail to
be registered because they neither die nor
attend hospital. Since they similarly do
not appear in our comparison lists the
gross underestimate of cancer incidence
afforded by the registry data is slightly
greater than is implied by the proportion
of listed cases that were registered. Table
IV presents the completeness proportions
duly adjusted for this source of under-
ascertainment. They are marginally less
than those derived from simple compari-
son. Since the correction factor for estimat-
ing the number of surviving cases who do
not attend hospital is a product of the
total number of cases registered, the
proportion of non-fatal cases each year
and the proportion who do not attend
hospital, it will vary from registry to
registry. It should, however, be possible
for each registry to estimate this factor by
analysing its data.
DISCUSSION
Cases of cancer fail to be registered if
they are not diagnosed, if they are not
treated in hospital but survive, or if those
responsible for their diagnosis and treat-
ment fail to mention the diagnosis on case
notes or death certificates. It is perhaps
not altogether surprising that cases that
appear in special lists should also appear
in cancer registries, since they have been
diagnosed and treated in hospital and the
diagnosis has been committed to paper.
WTe do have good general grounds for
supposing that our special lists are very
complete and reliable and it is encouraging
that those responsible for maintaining
suich lists also take registration seriously.
With regard to the correction for sur-
viving cancer cases lost to registration
because they never attended hospital, it is
important to explain the basis of the
calculation. The exclusive death-certificate
registrations who never attended hospital
(40) include cases too advanced to benefit
from treatment. Among these survival
would be poor. Therefore, if 40o of dead
cases never attended hospital, one would
expect the proportion of survivors who
never attended to be lower. On the other
hand the figure of 340o, as the proportion
of surviving cases for each year's regis-
tration, is derived from all sites of cancer
(Table I), whereas the data to which the
correction is being applied relate to sites
of moderate or low fatality. The propor-
tion ofsurvivors in the latter group should
be higher than 340o. The calculation ofthe
correction factor based on the propor-
tions should be valid since the marginal
discrepancies in both directions would
compensate for each other.
What calls for some explanation is the
variation in completeness of registration
of our listed patients. The main variation
(Tables II and III) is associated with
diagnosis and institution. The explanations
that seem most plausible appear to be
related to the probability either of early
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1
3
4
5
Corrected %
completeness
(IOOR)
N+s
94 -1
94 5
84-3
97 3
97-1
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death or of sustained doctor-patient con-
tact-both of which favour complete
registration. The most puzzling item is
the relatively low rate of registration of
cervix cancer.
Comparison of Tables II and III makes
it evident that only one hospital, C, and
only one site, cervix, have levels of com-
pleteness less than 90%. In fact these 2
findings are associated since all cases of
cervical cancer in the study had some
part of their treatment at that hospital.
The low level of completeness for cervical
cancer may be due partly to the low
proportion of registrations encountered
generally in hospital C. Other possible
reasons for this low level include the
natural history of the disease-its long
incubation period, spontaneous remission
in some cases and the comparatively long
survival ofpatients-or the fact that some
early cases identified by cytological smears
fail to attend the gynaecological unit sub-
sequently for further investigation and
specific treatment. Also some of those
initially diagnosed later turn out to be
histologically negative and are therefore
not notified or registered.
It is clearly to the advantage of cancer
registration to have well maintained listing
of cases for various purposes. A possibly
valuable lesson that emerges is that cancer
registries might usefully promote and
support the creation of such special lists
for use in clinical care and research. To be
useful they should provide the kind of
data that are required for clinical and
research purposes and should be associated
with persons or institutions with a strong
involvement in their utilization.
We are grateful to Trevor Benn, statistician to
the Regional Cancer Registry, and to members of
the registry clerical staff. We also gratefully acknow-
ledge the helpful cooperation of clinicians and
pathologists whose lists were used.
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